| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Pathology,*
Brigham and Women’s
Hospital, Boston, Massachusetts; the Department of
Pathology,
Children’s Hospital Boston,
Massachusetts; and the Department of Pediatric
Oncology,§
Dana-Farber Cancer Institute,
Boston, Massachusetts; and the Department of
Pathology,
University of California, San
Diego Medical Center, San Diego, California
Inflammatory myofibroblastic tumors (IMTs) are neoplastic mesenchymal proliferations featuring an inflammatory infiltrate composed primarily of lymphocytes and plasma cells. The myofibroblastic cells in some IMTs contain chromosomal rearrangements involving the ALK receptor tyrosine-kinase locus region (chromosome band 2p23). ALK—which is normally restricted in its expression to neural tissues—is expressed strikingly in the IMT cells with 2p23 rearrangements. We now report a recurrent oncogenic mechanism, in IMTs, in which tropomyosin (TPM) N-terminal coiled-coil domains are fused to the ALK C-terminal kinase domain. We have cloned two ALK fusion genes, TPM4-ALK and TPM3-ALK, which encode ~95-kd fusion oncoproteins characterized by constitutive kinase activity and tyrosylphosphorylation. Immunohistochemical and molecular correlations, in other IMTs, implicate non-TPM ALK oncoproteins that are predominantly cytoplasmic or pre- dominantly nuclear, presumably depending on the subcellular localization of the ALK fusion partner. Notably, a TPM3-ALK oncogene was reported recently in anaplastic lymphoma, and TPM3-ALK is thereby the first known fusion oncogene that transforms, in vivo, both mesenchymal and lymphoid human cell lineages.
This article has been cited by other articles:
 |
|
 |
|
  U. McDermott, A. J. Iafrate, N. S. Gray, T. Shioda, M. Classon, S. Maheswaran, W. Zhou, H. G. Choi, S. L. Smith, L. Dowell, et al. Genomic Alterations of Anaplastic Lymphoma Kinase May Sensitize Tumors to Anaplastic Lymphoma Kinase Inhibitors Cancer Res., May 1, 2008; 68(9): 3389 - 3395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B C Gleason and J L Hornick Inflammatory myofibroblastic tumours: where are we now? J. Clin. Pathol., April 1, 2008; 61(4): 428 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Slater and J. Shipley Clinical relevance of molecular genetics to paediatric sarcomas J. Clin. Pathol., November 1, 2007; 60(11): 1187 - 1194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Amin and R. Lai Pathobiology of ALK+ anaplastic large-cell lymphoma Blood, October 1, 2007; 110(7): 2259 - 2267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Lim and K. S. J. Elenitoba-Johnson Mass Spectrometry-based Proteomic Studies of Human Anaplastic Large Cell Lymphoma Mol. Cell. Proteomics, October 1, 2006; 5(10): 1787 - 1798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shigematsu, Y. Sano, S. Kasahara, H. Yanai, and H. Date Calcifying fibrous tumor arising from the heart. J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): e21 - e22. [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. J. Elenitoba-Johnson, D. K. Crockett, J. A. Schumacher, S. D. Jenson, C. M. Coffin, A. L. Rockwood, and M. S. Lim Proteomic identification of oncogenic chromosomal translocation partners encoding chimeric anaplastic lymphoma kinase fusion proteins PNAS, May 9, 2006; 103(19): 7402 - 7407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Klener, M. Szynal, Y. Cleuter, M. Merimi, H. Duvillier, F. Lallemand, C. Bagnis, P. Griebel, C. Sotiriou, A. Burny, et al. Insights into Gene Expression Changes Impacting B-Cell Transformation: Cross-Species Microarray Analysis of Bovine Leukemia Virus Tax-Responsive Genes in Ovine B Cells J. Virol., February 15, 2006; 80(4): 1922 - 1938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Wan, M. S. Albom, L. Lu, M. R. Quail, N. C. Becknell, L. R. Weinberg, D. R. Reddy, B. P. Holskin, T. S. Angeles, T. L. Underiner, et al. Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells Blood, February 15, 2006; 107(4): 1617 - 1623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Melloni, A. Carretta, P. Ciriaco, G. Arrigoni, S. Fieschi, N. Rizzo, E. Bonacina, G. Augello, P. A. Belloni, and P. Zannini Inflammatory Pseudotumor of the Lung in Adults Ann. Thorac. Surg., February 1, 2005; 79(2): 426 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Cheuk and J. K. C. Chan Subcellular Localization of Immunohistochemical Signals: Knowledge of the Ultrastructural or Biologic Features of the Antigens Helps Predict the Signal Localization and Proper Interpretation of Immunostains International Journal of Surgical Pathology, July 1, 2004; 12(3): 185 - 206. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Sakurai, T. Hasegawa, S.-i. Watanabe, K. Suzuki, H. Asamura, and R. Tsuchiya Inflammatory myofibroblastic tumor of the lung Eur. J. Cardiothorac. Surg., February 1, 2004; 25(2): 155 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Tamborini, L. Bonadiman, A. Greco, A. Gronchi, C. Riva, R. Bertulli, P. G. Casali, M. A. Pierotti, and S. Pilotti Expression of Ligand-Activated KIT and Platelet-Derived Growth Factor Receptor {beta} Tyrosine Kinase Receptors in Synovial Sarcoma Clin. Cancer Res., February 1, 2004; 10(3): 938 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Gascoyne, L. Lamant, J. I. Martin-Subero, V. S. Lestou, N. L. Harris, H.-K. Muller-Hermelink, J. F. Seymour, L. J. Campbell, D. E. Horsman, I. Auvigne, et al. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases Blood, October 1, 2003; 102(7): 2568 - 2573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Gale, N Zidar, J Podboj, M Volavsek, and B Luzar Inflammatory myofibroblastic tumour of paranasal sinuses with fatal outcome: reactive lesion or tumour? J. Clin. Pathol., September 1, 2003; 56(9): 715 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Debiec-Rychter, R. Croes, R. De Vos, P. Marynen, T. Roskams, A. Hagemeijer, R. Lombaerts, and R. Sciot Complex Genomic Rearrangement of ALK Loci Associated with Integrated Human Epstein-Barr Virus in a Post-Transplant Myogenic Liver Tumor Am. J. Pathol., September 1, 2003; 163(3): 913 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-C. Chang and V. B. Shidham Molecular Genetics of Pediatric Soft Tissue Tumors: Clinical Application J. Mol. Diagn., August 1, 2003; 5(3): 143 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Shing, D. J. McMullan, P. Roberts, K. Smith, S.-F. Chin, J. Nicholson, R. M. Tillman, P. Ramani, C. Cullinane, and N. Coleman FUS/ERG Gene Fusions in Ewing's Tumors Cancer Res., August 1, 2003; 63(15): 4568 - 4576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Reading, S. D. Jenson, J. K. Smith, M. S. Lim, and K. S. J. Elenitoba-Johnson 5'-(RACE) Identification of Rare ALK Fusion Partner in Anaplastic Large Cell Lymphoma J. Mol. Diagn., May 1, 2003; 5(2): 136 - 140. [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Kutok and J. C. Aster Molecular Biology of Anaplastic Lymphoma Kinase-Positive Anaplastic Large-Cell Lymphoma J. Clin. Oncol., September 1, 2002; 20(17): 3691 - 3702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Nascimento, R. Ruiz, J. L. Hornick, and C. D. M. Fletcher Calcifying Fibrous 'Pseudotumor': Clinicopathologic Study of 15 Cases and Analysis of its Relationship to Inflammatory Myofibroblastic Tumor International Journal of Surgical Pathology, July 1, 2002; 10(3): 189 - 196. [Abstract] [PDF]
|
|
|
|
|
|
B. Falini and D. Y. Mason Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry Blood, January 15, 2002; 99(2): 409 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Rubin, S. Singer, C. Tsao, A. Duensing, M. L. Lux, R. Ruiz, M. K. Hibbard, C.-J. Chen, S. Xiao, D. A. Tuveson, et al. KIT Activation Is a Ubiquitous Feature of Gastrointestinal Stromal Tumors Cancer Res., November 1, 2001; 61(22): 8118 - 8121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Meech, L. McGavran, L. F. Odom, X. Liang, L. Meltesen, J. Gump, Q. Wei, S. Carlsen, and S. P. Hunger Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4-anaplastic lymphoma kinase gene fusion Blood, August 15, 2001; 98(4): 1209 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Bridge, M. Kanamori, Z. Ma, D. Pickering, D. A. Hill, W. Lydiatt, M. Y. Lui, G. W. B. Colleoni, C. R. Antonescu, M. Ladanyi, et al. Fusion of the ALK Gene to the Clathrin Heavy Chain Gene, CLTC, in Inflammatory Myofibroblastic Tumor Am. J. Pathol., August 1, 2001; 159(2): 411 - 415. [Abstract] [Full Text]
|
|
|
|
|
|
R. Suzuki, M. Seto, S. Nakamura, A. Nakagawa, K. Hara, and K. Takeuchi Sarcomatoid Variant of Anaplastic Large Cell Lymphoma with Cytoplasmic ALK and {{alpha}}-Smooth Muscle Actin Expression: A Mimic of Inflammatory Myofibroblastic Tumor Am. J. Pathol., July 1, 2001; 159(1): 383 - 384. [Full Text] [PDF]
|
|
|
|
|
|
B. Maes, V. Vanhentenrijk, I. Wlodarska, J. Cools, B. Peeters, P. Marynen, and C. De Wolf-Peeters The NPM-ALK and the ATIC-ALK Fusion Genes Can Be Detected in Non-Neoplastic Cells Am. J. Pathol., June 1, 2001; 158(6): 2185 - 2193. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
